Weghaupt K, Gerstner G J, Kucera H
Gynecol Oncol. 1984 Jan;17(1):58-63. doi: 10.1016/0090-8258(84)90060-x.
Sixty-two patients with primary carcinoma of the female urethra were treated with a combined radiation therapy (high-dose intracavitary vaginal radium and external beam). Treatment was strictly individualized, but an administered tumor dose of 5500-7000 rad (55-70 Gy) was always attempted. Forty-two patients (67.7%) had tumors of the anterior urethra, and in 20 women (32.3%) the posterior urethra was involved. In 19 patients (30.6%) the clinical diagnosis of lymph node involvement was made. The overall 5-year-survival rate was 64.5%. Patients with anterior urethral carcinoma had a higher 5-year-survival rate (71.4%) than patients with posterior carcinoma (50.0%). The favorable results underline the substantial role of radiation therapy for this malignancy.
62例女性尿道原发性癌患者接受了联合放射治疗（高剂量腔内阴道镭疗和外照射）。治疗严格个体化，但总是尝试给予5500 - 7000拉德（55 - 70戈瑞）的肿瘤剂量。42例患者（67.7%）为前尿道肿瘤，20例女性（32.3%）后尿道受累。19例患者（30.6%）临床诊断有淋巴结受累。总体5年生存率为64.5%。前尿道癌患者的5年生存率（71.4%）高于后尿道癌患者（50.0%）。这些良好结果突显了放射治疗对这种恶性肿瘤的重要作用。
